Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YKYY018 in Adult Participants With Respiratory Syncytial Virus Infection
NCT07808268Phase 2Not yet recruiting
- Sponsor
- Yuekang Pharmaceutical
- Start
- Oct 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of YKYY018 in respiratory syncytial virus infection (RSV), sponsored by Yuekang Pharmaceutical. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
YKYY018
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07808268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808268.